At time of analysis 28/30 patients completed 24Ws of therapy.
| HIV stage(%) | Reasons starting(%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age(year) | Sex (%) (Female) | A | B | C | Median CD4(cell/ mm3)<> <> <> | VF | AEs | Simplification Therapy | (%)Resistance Testing(Pis) <> <> <> | |
| VL<50 copies/ml (n=11) | 41.7(95% CI: 37.1-46.3) | 54.5 | 54.5 | 9.1 | 36.4 | 527(IQR:441-792) | 0 | 72.7 | 27.3 | 18(negative) |
| VF(n=17) | 50.5(95% CI: 45.6-55.4) | 29.4 | 11.8 | 23.5 | 64.7 | 205(IQR:137-475) | 100 | 0 | 0 | 88.2(13.3% positive, none DRV mutation) <> <> <> |